Major deregulation? FDA withdraws several rules and regulations related to medical products
Almost a year ago, President Donald Trump told pharmaceutical executives that his administration would cut 75% to 80% of FDA regulations, “at a level no one has ever seen before.”
Since those comments last January, the FDA has withdrawn the most rulemakings of any Department of Health and Human Services agency, though only a handful are related to medical products (the others are tobacco related) and it’s unclear how the withdrawal of these proposals and regulations so far in 2017 will impact patient safety or industry burdens.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.